TD ASSET MANAGEMENT INC - REGENXBIO INC ownership

REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 188 filers reported holding REGENXBIO INC in Q4 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
TD ASSET MANAGEMENT INC ownership history of REGENXBIO INC
ValueSharesWeighting
Q4 2022$304,842
-9.0%
13,4410.0%0.00%
Q3 2022$335,000
+0.9%
13,4410.0%0.00%
Q2 2022$332,000
-51.5%
13,441
-34.8%
0.00%
-100.0%
Q1 2022$684,000
+1.5%
20,6000.0%0.00%0.0%
Q4 2021$674,000
-22.0%
20,6000.0%0.00%0.0%
Q3 2021$864,000
+32.5%
20,600
+2.2%
0.00%0.0%
Q2 2021$652,000
-5.2%
20,1650.0%0.00%0.0%
Q1 2021$688,000
-18.1%
20,165
+8.9%
0.00%0.0%
Q4 2020$840,000
+64.7%
18,5200.0%0.00%0.0%
Q3 2020$510,000
-25.2%
18,5200.0%0.00%0.0%
Q2 2020$682,000
+13.7%
18,5200.0%0.00%0.0%
Q1 2020$600,000
-36.9%
18,520
-20.2%
0.00%0.0%
Q4 2019$951,000
+1.9%
23,220
-11.4%
0.00%0.0%
Q3 2019$933,000
-46.3%
26,220
-22.5%
0.00%
-66.7%
Q2 2019$1,737,000
-14.2%
33,820
-4.2%
0.00%0.0%
Q1 2019$2,024,000
+125.1%
35,320
+64.9%
0.00%
+50.0%
Q4 2018$899,000
-26.5%
21,420
+32.2%
0.00%0.0%
Q3 2018$1,223,000
+25.3%
16,200
+19.1%
0.00%
+100.0%
Q2 2018$976,000
+200.3%
13,600
+24.8%
0.00%
Q1 2018$325,000
-8.7%
10,900
+1.9%
0.00%
-100.0%
Q4 2017$356,000
+7.6%
10,700
-40.1%
0.00%0.0%
Q4 2016$331,000
+3.8%
17,866
-21.5%
0.00%0.0%
Q3 2016$319,000
+72.4%
22,765
-1.7%
0.00%
Q2 2016$185,000
-26.0%
23,1650.0%0.00%
Q1 2016$250,00023,1650.00%
Other shareholders
REGENXBIO INC shareholders Q4 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 847,424$13,948,59912.64%
Sonic GP LLC 518,079$8,527,5808.28%
MPM BioImpact LLC 656,718$10,809,5782.89%
Redmile Group, LLC 2,574,042$42,368,7312.02%
ArchPoint Investors 224,278$3,691,6161.41%
WS MANAGEMENT LLLP 618,131$10,174,4360.82%
Redwood Wealth Management Group, LLC 14,360$236,3660.28%
HARBOR CAPITAL ADVISORS, INC. 48,559$799,2810.17%
PRENTISS SMITH & CO INC 11,240$185,0100.14%
LIBERTY ONE INVESTMENT MANAGEMENT, LLC 36,522$601,1520.09%
View complete list of REGENXBIO INC shareholders